Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 325 mg; 10 mg; 200 mg; 5 mg Tablet, Coated, 13,706-count — NDC 63824-561-90 (Billing 63824-0561-90)
This is a package of 13,706 tablets of Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 325 mg; 10 mg; 200 mg; 5 mg Tablet, Coated from RB Health (US) LLC, first listed with the FDA Mar 2013 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.
NDC database record
One package, one record: these facts belong to NDC 63824-561-90 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 63824 labeler · 561 product · 90 package
- Package marketed since
- Mar 15, 2013
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 6382456190 5
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
This is a coated tablet containing four active ingredients commonly combined in over-the-counter cold and cough products. Acetaminophen is typically used to reduce fever and relieve pain, while dextromethorphan is commonly used to suppress cough. Guaifenesin functions as an expectorant, intended to help thin mucus and make cough more productive. Phenylephrine hydrochloride is a decongestant typically used to relieve nasal and sinus congestion.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 20, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 63824-0561-90 You're viewing this Main listing | 13706 TABLET, COATED in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK | — | — | Active |
| 63824-0561-99 63824-561-99 | 12564 TABLET, COATED in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK | — | — | Active |
You're viewing the largest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 63824-0561-99?
What NDC number is used to bill for this package of Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 325 mg; 10 mg; 200 mg; 5 mg Tablet, Coated?
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 20, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from RB Health (US) LLC labeler code 63824
- Maximum Strength Mucinex Fast-Max Cold and Flu ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE 650 mg/20mL; 20 mg/20mL; 400 mg/20mL; 10 mg/20mL Solution NDC 63824-527-03
- Mucinex Fast-Max DM Max Honey and Berry Flavor Dextromethorphan Hydrobromide and Guaifenesin 20 mg/20mL; 400 mg/20mL Solution NDC 63824-535-66
- Mucinex Fast-Max Chest Congestion Honey and Berry Flavor Guaifenesin 400 mg/20mL Solution NDC 63824-537-66
- Mucinex Fast-Max Severe Congestion and Cough dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride 20 mg/20mL; 400 mg/20mL; 10 mg/20mL Solution NDC 63824-540-66
- Maximum Strength Mucinex Fast-Max Cold and Flu acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride 650 mg/20mL; 20 mg/20mL; 400 mg/20mL; 10 mg/20mL Solution NDC 63824-548-33
- Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 10 mg; 200 mg; 5 mg Tablet, Coated NDC 63824-553-90
- Maximum Strength Mucinex Fast-Max Cold and Flu Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 325 mg; 10 mg; 200 mg; 5 mg Tablet, Film Coated NDC 63824-575-04
- Mucinex Fast-Max Cold, Flu and Sore Throat Acetaminophen, Dextromethorphan hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride 325 mg; 10 mg; 200 mg; 5 mg Capsule, Liquid Filled NDC 63824-591-16
- Mucinex Sinus-Max Severe Congestion and Pain ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE 325 mg; 10 mg; 5 mg Capsule, Liquid Filled NDC 63824-692-16
- Mucinex Sinus-Max Pressure, Pain and Cough ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE 325 mg; 10 mg; 200 mg; 5 mg Capsule, Liquid Filled NDC 63824-693-08
- Cepacol Extra Strength Sore Throat cherry Benzocaine and Menthol 15 mg; 3.6 mg Lozenge NDC 63824-713-04
- Cepacol Extra Strength Sore Throat honey lemon Benzocaine and Menthol 15 mg; 2.6 mg Lozenge NDC 63824-732-16
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: RB Health (US) LLC supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |